ArticleWorld journal of gastroenterology2005

Antitumor effect of Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma.

Bu-Dong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.